Aehr Test Systems
AEHR
NASDAQ
11/30/2023 | 08/31/2023 | 05/31/2023 | 02/28/2023 | 11/30/2022 | |
---|---|---|---|---|---|
Revenue | 21.43M | 20.62M | 22.27M | 17.21M | 14.82M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 21.43M | 20.62M | 22.27M | 17.21M | 14.82M |
Cost of Revenue | 10.47M | 10.64M | 10.79M | 8.33M | 6.90M |
Gross Profit | 10.96M | 9.98M | 11.48M | 8.88M | 7.91M |
SG&A Expenses | 3.52M | 3.41M | 3.59M | 3.25M | 2.88M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 15.96M | 16.51M | 16.63M | 13.41M | 11.33M |
Operating Income | 5.47M | 4.12M | 5.64M | 3.79M | 3.49M |
Income Before Tax | 6.11M | 4.69M | 6.12M | 4.15M | 3.74M |
Income Tax Expenses | 20.00K | 16.00K | 11.00K | 17.00K | 18.00K |
Earnings from Continuing Operations | 6.09M | 4.67M | 6.11M | 4.13M | 3.73M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 6.09M | 4.67M | 6.11M | 4.13M | 3.73M |
EBIT | 5.47M | 4.12M | 5.64M | 3.79M | 3.49M |
EBITDA | 5.61M | 4.25M | 5.75M | 3.94M | 3.61M |
EPS Basic | 0.21 | 0.16 | 0.22 | 0.15 | 0.14 |
Normalized Basic EPS | 0.13 | 0.10 | 0.13 | 0.09 | 0.08 |
EPS Diluted | 0.20 | 0.16 | 0.21 | 0.14 | 0.13 |
Normalized Diluted EPS | 0.13 | 0.10 | 0.13 | 0.09 | 0.08 |
Average Basic Shares Outstanding | 28.80M | 28.65M | 28.43M | 27.89M | 27.58M |
Average Diluted Shares Outstanding | 29.77M | 29.63M | 29.57M | 29.37M | 29.08M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |